Does PEMBROLIZUMAB Cause Pericardial effusion? 362 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 362 reports of Pericardial effusion have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.4% of all adverse event reports for PEMBROLIZUMAB.
362
Reports of Pericardial effusion with PEMBROLIZUMAB
0.4%
of all PEMBROLIZUMAB reports
69
Deaths
186
Hospitalizations
How Dangerous Is Pericardial effusion From PEMBROLIZUMAB?
Of the 362 reports, 69 (19.1%) resulted in death, 186 (51.4%) required hospitalization, and 40 (11.0%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
Yes, Pericardial effusion is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PREDNISONE (339)
Which PEMBROLIZUMAB Alternatives Have Lower Pericardial effusion Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G